The Urinary Phosphate to Serum Fibroblast Growth Factor 23 Ratio Is a Useful Marker of Atherosclerosis in Early-Stage Chronic Kidney Disease

• Hodaka Yamada ,

  * E-mail: hyamada0510@jichi.ac.jp

  Affiliation Department of Medicine, Jichi Medical University Saitama Medical Center, 1-847 Amanuma-cho, Omiya-ku, Saitama, 330-8503, Japan

  ⨯
• Makoto Kuro-o,

  Affiliation Center for Molecular Medicine, Jichi Medical University, 3311-1 Yakushiji Shimotsuke, Tochigi, 329-0498, Japan

  ⨯
• Kazuo Hara,

  Affiliation Department of Medicine, Jichi Medical University Saitama Medical Center, 1-847 Amanuma-cho, Omiya-ku, Saitama, 330-8503, Japan

  ⨯
• Yuichiro Ueda,

  Affiliation Department of Medicine, Jichi Medical University Saitama Medical Center, 1-847 Amanuma-cho, Omiya-ku, Saitama, 330-8503, Japan

  ⨯
• Ikuyo Kusaka,

  Affiliation Department of Medicine, Jichi Medical University Saitama Medical Center, 1-847 Amanuma-cho, Omiya-ku, Saitama, 330-8503, Japan

  ⨯
• Masafumi Kakei,

  Affiliation Department of Medicine, Jichi Medical University Saitama Medical Center, 1-847 Amanuma-cho, Omiya-ku, Saitama, 330-8503, Japan

  ⨯
• San-e Ishikawa

  Affiliation Division of Endocrinology and Metabolism, International University of Health and Welfare Hospital, 537-3 Iguchi, Nasushiobara, Tochigi, 329-2763, Japan

  ⨯